● Recruiting

A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma

Condition: Soft Tissue Sarcoma · Bone Sarcoma · Sponsor: M.D. Anderson Cancer Center

PhasePhase 1

Planned participants40

Who can joinAll sexes, 12 Years to no upper limit

Healthy volunteersNo

About this study

To find a recommended dose of attIL2-T cell therapy that can be given to patients with soft tissue or bone sarcomas and to see if it can help to control the disease.

This description comes directly from the study's public registry record.

Talk to the study team

John Livingston, MD · (713) 792-3626 · jalivingston@mdanderson.org

Always discuss trial participation with your own doctor first.

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05621668